More about

Renin-Angiotensin System

News
February 07, 2025
3 min read
Save

Wegovy may reduce need for antihypertensive, lipid-lowering therapies

Adults receiving semaglutide for the treatment of obesity were more likely to have antihypertensive or lipid-lowering therapy tapered or discontinued than those receiving placebo, according to data from the STEP trials.

News
August 30, 2024
2 min read
Save

Choice to halt RAS therapy before major surgery can be left to patient, physician

Discontinuation of renin-angiotensin system inhibitor therapy before major noncardiac surgery did not appear to affect postoperative outcomes vs. treatment continuation, a speaker reported.

News
May 29, 2024
2 min read
Save

Renin-angiotensin system blockade beneficial for Black and non-Black patients with HFrEF

Renin-angiotensin system blockade conferred similar mortality benefits for Black vs. non-Black patients with HF, and despite less benefit for hospitalization for Black patients, absolute benefit was comparable, researchers reported.

News
March 18, 2024
6 min read
Save

Aldosterone: The hidden hormone linking hypertension and obesity, and a potential target

An op-ed published in February by Tom Frieden, MD, MPH, former director of the CDC, described hypertension as “the deadliest but most neglected and widespread pandemic of our time” — and he’s right.

News
December 01, 2023
1 min read
Save

Two post-approval outcome trials of anti-hyperkalemia drug stopped for logistical reasons

AstraZeneca announced that two post-approval randomized heart- and kidney-related outcome studies of its anti-hyperkalemia drug have been stopped due to slow enrollment and low event rates.

News
November 15, 2023
3 min read
Save

Intensive medication optimization cost-effective in patients hospitalized with HFrEF

PHILADELPHIA — An intensive medication optimization program for patients hospitalized with HF with reduced ejection fraction would be cost-effective, researchers reported at the American Heart Association Scientific Sessions.

News
August 17, 2023
2 min read
Save

Patients with hyperkalemia less likely to receive RAAS inhibitors, have worse HF outcomes

Chinese adults with HF and dyskalemia were less likely to receive renin-angiotensin-aldosterone system inhibitors than patients with normokalemia, and those with hyperkalemia were more likely to experience worsening HF or CV death.

News
July 17, 2023
2 min read
Save

Diuretic with renin-angiotensin system inhibitor slows CKD progression

Adding a diuretic to renin-angiotensin system inhibitor therapy lowered the risk for disease progression in patients with chronic kidney disease compared with using a calcium channel blocker, according to study data.

News
May 30, 2023
3 min read
Save

Early, rapid uptitration of HF therapies after discharge reduces death, readmission risk

Rapid uptitration of medical therapy early after hospitalization for acute HF improves prognosis independent of left ventricular ejection fraction, according to a prespecified analysis of the STRONG-HF trial.

News
April 10, 2023
3 min read
Save

‘Dips’ in eGFR after sacubitril/valsartan transition should not stall HF therapy

Declines in renal function observed during transition from a renin-angiotensin system inhibitor to sacubitril/valsartan for HF are variable but usually small and partially recoverable for most patients, researchers reported.

View more